Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their ...
News-Medical.Net on MSN
Alzheimer’s plaques decline after CAR-T immune cell treatment in preclinical study
By Hugo Francisco de Souza A novel CAR-T cell approach targets amyloid plaques in preclinical Alzheimer models, raising the ...
Tiny amounts of signaling molecules hang around on macrophages to pump up responses to repeated threats, offering a target to treat autoimmune conditions.
H2H will evaluate the efficacy and safety of rondecabtagene autoleucel (ronde-cel) versus Investigator’s choice of approved CD19 CAR ...
An fresh look at trial results that propelled the only FDA approval of a chimeric antigen receptor (CAR) T-cell therapy for mantle cell lymphoma (MCL) shows prior treatment with ibrutinib, a ...
A 20-year study found a brain game that boosts speed and splits attention helped prevent Alzheimer’s and other dementias.
ScienceAlert on MSN
Memory Loss in Alzheimer's Linked to Problems With The Brain's 'Replay Mode'
To consolidate memories, our brains replay them during periods of rest as a kind of 'replay mode'. A new mouse study suggests ...
Researchers have created the most detailed maps to date showing how genes regulate one another across different types of brain cells affected by Alzheimer’s disease.
Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team ...
Study identified numerous influential “hub genes” that offer promising new targets for early detection and therapeutic intervention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results